Hermann Brustmann

Summary

Publications

  1. ncbi immunohistochemical expression of survivin and γ-H2AX in vulvar intraepithelial neoplasia and low-stage squamous cell carcinoma
    Hermann Brustmann
    Department of Pathology, Landesklinikum Thermenregion Moedling, Sr Maria Restitutagasse 12, Moedling, Austria
    Int J Gynecol Pathol 30:583-90. 2011
  2. ncbi The accuracy of frozen section analysis in ultrasound- guided core needle biopsy of breast lesions
    Andreas H Brunner
    Department of Obstetrics and Gynecology, Division of Gynecology and Gynecologic Oncology, Landesklinikum Moedling Vienna, Austria
    BMC Cancer 9:341. 2009
  3. ncbi Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Sr Maria Restitutagasse 12, A 2340 Moedling, Vienna, Austria
    Pathol Res Pract 203:65-72. 2007
  4. ncbi Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB-1 immunoreactivity
    Hermann Brustmann
    Department of Pathology, Thermenklinikum Moedling Vienna, Austria
    Int J Gynecol Pathol 26:481-9. 2007
  5. ncbi Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Moedling Vienna, Austria
    Int J Gynecol Pathol 26:147-53. 2007
  6. ncbi Paraganglioma of the vagina: report of a case
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Sr Maria Restitutagasse 12, A 2340 Moedling Vienna, Austria
    Pathol Res Pract 203:189-92. 2007
  7. ncbi Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervix
    Hermann Brustmann
    Department of Pathology, Landesklinikum Thermenregion, A 2340 Moedling, Austria
    Ann Diagn Pathol 13:303-7. 2009
  8. ncbi Intestinal metastases in a squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case report
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, A 2340 Moedling Vienna, Austria
    Ann Diagn Pathol 10:374-5. 2006
  9. ncbi DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Sr Maria Restitutagasse, 12A 2340 Moedling Vienna, Austria
    Pathol Res Pract 202:713-20. 2006
  10. ncbi Myxoglobulosis of the appendix associated with a proximal carcinoid and a pseudodiverticulum
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Moedling, Vienna, Austria
    Ann Diagn Pathol 10:166-8. 2006

Collaborators

Detail Information

Publications26

  1. ncbi immunohistochemical expression of survivin and γ-H2AX in vulvar intraepithelial neoplasia and low-stage squamous cell carcinoma
    Hermann Brustmann
    Department of Pathology, Landesklinikum Thermenregion Moedling, Sr Maria Restitutagasse 12, Moedling, Austria
    Int J Gynecol Pathol 30:583-90. 2011
    ..Expression patterns were different for both factors, suggesting their involvement in different biologic mechanisms as an early event leading to resistance to apoptosis in vulvar carcinogenesis...
  2. ncbi The accuracy of frozen section analysis in ultrasound- guided core needle biopsy of breast lesions
    Andreas H Brunner
    Department of Obstetrics and Gynecology, Division of Gynecology and Gynecologic Oncology, Landesklinikum Moedling Vienna, Austria
    BMC Cancer 9:341. 2009
    ..Limited data are available to evaluate the accuracy of frozen section analysis and ultrasound- guided core needle biopsy of the breast...
  3. ncbi Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Sr Maria Restitutagasse 12, A 2340 Moedling, Vienna, Austria
    Pathol Res Pract 203:65-72. 2007
    ..Immunoexpression of PARP and DFF45 is apparently altered in endometrial carcinomas as compared with non-neoplastic endometrial tissues, indicating impaired mechanisms of apoptosis in the former...
  4. ncbi Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB-1 immunoreactivity
    Hermann Brustmann
    Department of Pathology, Thermenklinikum Moedling Vienna, Austria
    Int J Gynecol Pathol 26:481-9. 2007
    ..The lack of a relationship with PIs suggests that mechanisms other than proliferation are involved in this process...
  5. ncbi Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Moedling Vienna, Austria
    Int J Gynecol Pathol 26:147-53. 2007
    ..0196, log-rank test). This study indicates that PARP expression is frequently upregulated in ovarian serous carcinomas, related with MIB-1 LIs and p53 expression, and may serve as a marker of aggressive behavior with prognostic value...
  6. ncbi Paraganglioma of the vagina: report of a case
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Sr Maria Restitutagasse 12, A 2340 Moedling Vienna, Austria
    Pathol Res Pract 203:189-92. 2007
    ..This case study reports on an endocrinologically inactive vaginal paraganglioma, emphasizing the morphological and immunohistochemical differential diagnoses...
  7. ncbi Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervix
    Hermann Brustmann
    Department of Pathology, Landesklinikum Thermenregion, A 2340 Moedling, Austria
    Ann Diagn Pathol 13:303-7. 2009
    ..However, Nup88 evaluation is of limited value as a diagnostic marker in individual cases...
  8. ncbi Intestinal metastases in a squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case report
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, A 2340 Moedling Vienna, Austria
    Ann Diagn Pathol 10:374-5. 2006
    ..In this unusual case, metastasizing SCC of the ovary arising in an MCT led to suppurative peritonitis and consequently to death of the patient. Follow-up procedures regarding intestinal spread could be useful in patients with SCC in MCT...
  9. ncbi DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Sr Maria Restitutagasse, 12A 2340 Moedling Vienna, Austria
    Pathol Res Pract 202:713-20. 2006
    ..0187). Apoptotic bodies were consistently DFF45-negative. This study indicates that DFF45 expression is frequently upregulated in ovarian serous carcinomas and may serve as a marker of aggressive behavior with prognostic value...
  10. ncbi Myxoglobulosis of the appendix associated with a proximal carcinoid and a pseudodiverticulum
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Moedling, Vienna, Austria
    Ann Diagn Pathol 10:166-8. 2006
    ..The latter may be an adjunct to the proximal partial obstruction of the appendiceal lumen by the carcinoid in the development of the spheroids of myxoglobulosis...
  11. ncbi Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Moedling Vienna, Austria
    Int J Gynecol Pathol 25:30-7. 2006
    ....
  12. ncbi Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Sr Maria Restitutagasse 12, A 2340 Moedling Vienna, Austria
    Gynecol Oncol 98:396-402. 2005
    ..This study investigated the expression of human telomerase reverse transcriptase (hTERT) and c-kit in a cohort of serous ovarian carcinomas by immunohistochemistry with regard to outcome and clinicopathologic variables...
  13. ncbi Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia
    Hermann Brustmann
    Department of Pathology, Thermenklinikum Moedling, Vienna, Austria
    Int J Gynecol Pathol 24:184-92. 2005
    ..1956). These results suggest that hTERT expression is closely related to proliferation, apoptosis, and high grade in endometrial carcinomas, reflecting cell cycle deregulation in endometrial carcinogenesis...
  14. ncbi Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with topoisomerase II alpha and prognosis
    Hermann Brustmann
    Department of Pathology, Thermenklinikumm, A 2340 Moedling Vienna, Austria
    Gynecol Oncol 95:16-22. 2004
    ....
  15. ncbi Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study
    Hermann Brustmann
    Department of Pathology, Thermenklinikum, Moedling Vienna, Austria
    Gynecol Oncol 92:268-76. 2004
    ....
  16. ncbi Galectin-3 expression in normal, hyperplastic, and neoplastic endometrial tissues
    Hermann Brustmann
    Department of Pathology, Landeskrankenhaus, Moedling Vienna, Austria
    Pathol Res Pract 199:151-8. 2003
    ..This study shows that galectin-3 expression increases from normal and hyperplastic to atypical hyperplastic and cancerous states of endometrial tissues, and provides further evidence of a relationship between AH and EC...
  17. ncbi Expression of phosphorylated histone H2AX (γ-H2AX) in normal and neoplastic squamous epithelia of the uterine cervix: an immunohistochemical study with epidermal growth factor receptor
    Hermann Brustmann
    Department of Pathology, Landesklinikum Thermenregion, Moedling, Austria
    Int J Gynecol Pathol 30:76-83. 2011
    ....
  18. ncbi Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome
    Hermann Brustmann
    Department of Pathology, Landesklinikum Thermenregion, Moedling, Austria
    Int J Gynecol Pathol 27:380-9. 2008
    ..6578 and P=0.0675, respectively). This study indicates that with regard to EGFR and cytoplasmic galectin-3 immunoexpression, multiple marker testing may be an adjunct in the identification of high-risk ovarian serous cancers...
  19. ncbi Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage
    Hermann Brustmann
    Department of Pathology, Landeskrankenhaus, Moedling Vienna, A 2340, Austria
    Gynecol Oncol 84:47-52. 2002
    ..The aim of this study was to investigate the expression of vascular endothelial growth factor (VEGF) by neoplastic cells in serous ovarian cystadenocarcinoma in relation to proliferation as determined by mitotic activity and to FIGO stage...
  20. ncbi Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53
    Andreas H Brunner
    Department of Obstetrics and Gynecology, Landesklinikum Thermenregion Moedling Vienna Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Sr Maria Restitutag 12, Moedling Vienna, Austria
    Int J Gynecol Pathol 30:569-75. 2011
    ..PAX 8 overexpression correlates with p53 expression and high-grade endometrial carcinomas but seems not to be useful as a prognostic parameter...
  21. ncbi Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions
    Hermann Brustmann
    Department of Pathology, Landeskrankenhaus, Moedling/Vienna, Austria
    Gynecol Oncol 86:192-9. 2002
    ..CONCLUSIONS: This study presents topo IIalpha and Ki-67 as useful proliferation-associated markers of vulvar epithelia...
  22. ncbi Apoptotic bodies as a morphological feature in serous ovarian carcinoma: correlation with nuclear grade, Ki-67 and mitotic indices
    Hermann Brustmann
    Department of Pathology, Landeskrankenhaus, Moedling/Vienna, Austria
    Pathol Res Pract 198:85-90. 2002
    ..The positive correlation between ABI and increasing nuclear grade, mitotic activity, and architectural growth pattern may indicate that apoptotic bodies are another variable for grading serous ovarian carcinomas...
  23. ncbi Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53
    Alfred Wellenhofer
    Department of Obstetrics and Gynecology, Landesklinikum Thermenregion Baden, Moedling, Austria
    Arch Pathol Lab Med 136:1359-65. 2012
    ..Human telomerase reverse transcriptase (hTERT), an enzyme that enables cells to overcome replicative senescence and to divide indefinitely, is overexpressed in many cancers and their precursor lesions...
  24. ncbi Expression of γ-H2AX in endometrial carcinomas: an immunohistochemical study with p53
    Andreas H Brunner
    Department of Obstetrics and Gynecology, Landesklinikum Thermenregion Moedling Vienna, Moedling Vienna, Austria
    Gynecol Oncol 121:206-11. 2011
    ..Increasing expression levels of γ-H2AX are associated with unfavourable prognostic factors in type I and type II endometrial carcinomas...
  25. ncbi Heterotopic liver in the right cardiac auricle
    Hermann Brustmann
    Department of Pathology, , Vienna, Austria
    Ann Diagn Pathol 6:248-9. 2002
    ..Another abnormal finding was a horseshoe kidney. To the best of the author's knowledge, this is the first report of heterotopic liver tissue in the cardiac auricles...
  26. ncbi Undifferentiated Endometrial Sarcoma of the Ovary: A Case Report with Review of Recent Literature and Discussion of Lacking Specificity of CD10 Immunoreactivity
    Hermann Brustmann
    Department of Pathology, Landesklinikum Thermenregion Mödling, Sr M Restitutagasse 12, Mödling A 2340, Austria
    Patholog Res Int 2010:608519. 2010
    ..Morphological features, extensive sampling, and appropriate immunohistochemistry including markers for cytokeratins and myogenic differentiation are mandatory to arrive at the correct diagnosis...